UDG Healthcare Competitors and Similar CompaniesClear all

UDG Healthcare's competitors and similar companies include Gerresheimer, Parazelsus, The BirgiMefar Group and Daewoong Pharmaceutical.

	UDG Healthcare UDG Healthcare is a company providing services to the healthcare and life sciences industries.	Gerresheimer Gerresheimer is a company that manufactures and sells packaging products and drug delivery systems.	Parazelsus Parazelsus is a company that operates as pharma and medical distributor.	The BirgiMefar Group The BirgiMefar Group is a manufacturer of medical products.	Daewoong Pharmaceutical Daewoong Pharmaceutical (대웅제약) is a company that provides pharmaceutical solutions and services.
Founding Date	Founding Date 1948	Founding Date 1864	Founding Date 2007	Founding Date 1963	Founding Date 2002
Type	Type Subsidiary	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare medical devices packaging pharma	Tags Healthcare medical devices paper and packaging pharma plastic	Tags Healthcare distribution logistics medical devices packaging pharma	Tags Healthcare medical devices packaging pharma	Tags Healthcare drug development medical devices pharma
Locations	Locations Dublin, IE HQ	Locations Düsseldorf, DE HQ Momignies, BE Anapolis, BR Sao Paulo, BR Sao Paulo, BR Chang Zhou Shi, CN Danyang, CN see more	Locations Karachi, PK HQ Kabol, AF Dhaka, BD Thane, IN	Locations TR HQ	Locations Seoul, KR HQ Hyderabad, IN Taguig City, PH Bangkok, TH
Employees	Employees 2,5121% increase	Employees 13,632	Employees 472% increase	Employees 430	Employees 1,669
Financial
Revenue (est.)	Revenue (est.) $1.3b (FY, 2020)	Revenue (est.) €2b (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₩2.1t (FY, 2025)
Cost of goods	Cost of goods $799.2m (FY, 2020)	Cost of goods €1.2b (FY, 2024)	Cost of goods N/A	Cost of goods N/A	Cost of goods (₩2b) (FY, 2025)
Gross profit	Gross profit $485.2m (FY, 2020)	Gross profit €870.9m (FY, 2024)	Gross profit N/A	Gross profit N/A	Gross profit ₩2.1t (FY, 2025)
Net income	Net income $92.8m (FY, 2020)	Net income €112.3m (FY, 2024)	Net income N/A	Net income N/A	Net income ₩227.9b (FY, 2025)